- :: Atom & Cosmos
- :: Body & Brain
- :: Earth
- :: Environment
- :: Genes & Cells
- :: Humans
- :: Life
- :: Matter & Energy
- :: Molecules
- :: Science & Society
- :: Other Topics
- :: Science News For Kids
Warning signs of preeclampsia, a complication of pregnancy that often forces a premature delivery, are revealed through blood tests (SN: 5/10/03, p. 293: Available to subscribers at http://www.sciencenews.org/articles/20030510/fob5.asp; 2/14/04, p. 100: Available to subscribers at http://www.sciencenews.org/articles/20040214/fob4.asp). Scientists now report that testing a woman's urine for falling concentrations of a hormone called placental growth factor (PlGF) can also tip off doctors to preeclampsia. These findings, if confirmed, suggest that pregnant women might someday have access to home kits that would alert them to get further tests, says Richard J. Levine of the National Institute of Child Health and Human Development in Bethesda, Md.
He and his colleagues examined urine obtained from 238 women at various times during pregnancy. Half had gone on to develop preeclampsia, which is marked by high blood pressure and in some cases, seizures. The other women had continued their uncomplicated pregnancies. Women who developed preeclampsia, which appears in the third trimester, had less PlGF in their urine in the seventh month, the team reports in the Jan. 5 Journal of the American Medical Association.
Levine says that if a woman were to show low readings of urinary PlGF and other signs of preeclampsia, doctors would tightly monitor her blood pressure and, in some cases, prescribe medication and admit her to a hospital.
PlGF and another hormone orchestrate blood vessel growth in the placenta, enabling the mother to nourish her fetus, Levine says.
Found in: Biomedicine
- Francisco, E. 2004. Pregnancy alert: Proteins may predict preeclampsia. Science News 165(Feb. 14):100. Available to subscribers at [Go to].
Levine, R.J. . . . R. Thadani, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine 350(Feb. 12):672-683. Abstract available at [Go to].
Maynard, S.E. . . . and S.A. Karumanchi, et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation 111(March 1):649-658. Available at [Go to].
Morgan, K. 2003. Pregnancy woe uncovered: Protein may underlie preeclampsia. Science News 163(March 8):147. Available at [Go to].
Savvidou, M.D. . . . and K.H. Nicolaides. 2003. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361(May 3):1511-1517. Summary available at [Go to].
Seppa, N. 2003. Preeclampsia progress: Blood test for predicting pregnancy problems. Science News 163(May 10):293. Available to subscribers at [Go to].
Thadani, R. . . . R.J. Levine, et al. 2004. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. Journal of Clinical Endocrinology and Metabolism 89(February):770-775. Abstract available at [Go to].
- Richard J. Levine
National Institute of Child Health and Human Development
National Institutes of Health
Building 6100
Room 7B03
Bethesda, MD 20892

Please login or register to participate.